These include the downregulation of natural anticoagulants present on the EC surface (TFPI, TM, and EPCR) mediated by TNF-α and IL-1β, as demonstrated in both acute and chronic inflammation [34,35], and variation of protein S and upregulation of endothelial adhesive molecule expression. The gene discussed is PROS1; the disease is inflammation.